T. Shigeta

Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.

T. Murohara, Y. Bando, M. Aoyama, 2013, American journal of physiology. Heart and circulatory physiology.

cardiac steatosis and oxidative stress in type 2 diabetes. 2

T. Murohara, Y. Bando, M. Aoyama, 2013 .

Mitochondria in Cardiovascular Physiology and Disease Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes

T. Murohara, Y. Bando, M. Aoyama, 2013 .

Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing 1 cardiac steatosis and oxidative stress in type 2 diabetes.

T. Murohara, Y. Bando, M. Aoyama, 2013 .

Dipeptidyl Peptidase-4 Modulates Left Ventricular Dysfunction in Chronic Heart Failure via Angiogenesis-Dependent and -Independent Actions

T. Murohara, K. Nagata, A. Hirashiki, 2012, Circulation.

Predictive value of abdominal aortic calcification index for mid-term cardiovascular events in patients with acute coronary syndrome

T. Murohara, H. Ishii, Susumu Suzuki, 2019, Heart and Vessels.

Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53.

T. Murohara, Y. Bando, A. Monji, 2011, Journal of atherosclerosis and thrombosis.

The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.

T. Murohara, T. Hibino, T. Okumura, 2023, Journal of cardiology.